Ultralife Corporation (ULBI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Ultralife Corporation stock (ULBI) is currently trading at $6.43. Ultralife Corporation PS ratio (Price-to-Sales) is 0.56. Analyst consensus price target for ULBI is $14.00. WallStSmart rates ULBI as Sell.
- ULBI PE ratio analysis and historical PE chart
- ULBI PS ratio (Price-to-Sales) history and trend
- ULBI intrinsic value — DCF, Graham Number, EPV models
- ULBI stock price prediction 2025 2026 2027 2028 2029 2030
- ULBI fair value vs current price
- ULBI insider transactions and insider buying
- Is ULBI undervalued or overvalued?
- Ultralife Corporation financial analysis — revenue, earnings, cash flow
- ULBI Piotroski F-Score and Altman Z-Score
- ULBI analyst price target and Smart Rating
Ultralife Corporation
📊 No data available
Try selecting a different time range
Smart Analysis
Ultralife Corporation (ULBI) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around market cap and peg ratio. Mixed signals suggest waiting for clearer direction before acting.
Ultralife Corporation (ULBI) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
75.33% of shares held by major funds and institutions
Supporting Valuation Data
Ultralife Corporation (ULBI) Areas to Watch (7)
Company is destroying shareholder value
Earnings declining -72.10%, profits shrinking
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Very expensive relative to growth, significant premium
Micro-cap company with very limited liquidity and high volatility
Solid revenue growth at 10.60% per year
Ultralife Corporation (ULBI) Detailed Analysis Report
Overall Assessment
This company scores 44/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 3 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 1.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.56), Price/Book (0.83) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, EPS Growth, Profit Margin. Some valuation metrics including PEG Ratio (3.81) suggest expensive pricing. Growth concerns include Revenue Growth at 10.60%, EPS Growth at -72.10%, which may limit upside. Profitability pressure is visible in Return on Equity at -4.50%, Operating Margin at 3.25%, Profit Margin at -3.09%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -4.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 10.60% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
ULBI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
ULBI's Price-to-Sales ratio of 0.56x sits near its historical average of 0.53x (57th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 8% below its historical high of 0.61x set in Mar 2026, and 19% above its historical low of 0.47x in Mar 2026. Over the past 12 months, the PS ratio has expanded from ~0.5x, reflecting growing market expectations outpacing revenue growth.
Compare ULBI with Competitors
Top ELECTRICAL EQUIPMENT & PARTS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Ultralife Corporation (ULBI) · INDUSTRIALS › ELECTRICAL EQUIPMENT & PARTS
The Big Picture
Ultralife Corporation is in a turnaround phase, with management focused on restoring profitability. Revenue reached 191M with 11% growth year-over-year. The company is currently unprofitable, posting a -3.1% profit margin.
Key Findings
Generating 607,000 in free cash flow and 1M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -3.1% profit margin. The path to breakeven will be the key catalyst.
Earnings fell 72% YoY while revenue grew 11%. This gap usually reflects one-time items (tax benefits, write-offs) in the prior period, not an operational decline.
What to Watch Next
Debt management: total debt of 54M is significantly higher than cash (9M). Monitor refinancing risk.
Sector dynamics: monitor ELECTRICAL EQUIPMENT & PARTS industry trends, competitive moves, and regulatory changes that could impact Ultralife Corporation.
Bottom Line
Ultralife Corporation is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(5 last 3 months)
| Insider | Type | Shares |
|---|---|---|
WHITMORE, BRADFORD T Director, 10% Owner | Buy | +53,131 |
| Insider | Type | Shares |
|---|---|---|
WHITMORE, BRADFORD T Director, 10% Owner | Buy | +100,640 |
Data sourced from SEC Form 4 filings
Last updated: 10:11:39 AM
About Ultralife Corporation(ULBI)
NASDAQ
INDUSTRIALS
ELECTRICAL EQUIPMENT & PARTS
USA
Ultralife Corporation designs, manufactures, installs and maintains electrical, communication and electronic systems worldwide. The company is headquartered in Newark, New York.